series-a
Stage
1
Investors
About
Enzymit develops a proprietary AI-driven protein design platform to create novel enzymes for scalable, cell-free enzymatic biomanufacturing, enabling sustainable and cost-effective production of high-value molecules.
Explore Enzymit's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.